EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiome in non-alcoholic fatty liver disease

Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, Eugenia Bezirtzoglou, Elisavet Stavropoulou

Frontiers in Gastroenterology · 14.01.2025 · 3

DOI: 10.3389/fgstr.2024.1534431 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 14.01.2025. Verfasst von Anastasios Mpountouridis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Theagenio Cancer Hospital, Thessaloniki, Greece. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) has a rapidly growing incidence worldwide, affecting approximately one-third of world population. The disturbance of gut commensal bacteria impacting host’s homeostasis is referred to as gut dysbiosis. The gut microbiome contributes to the pathogenesis of NAFLD through various pathways. Gut microbiota is at constant interactions with the intestinal epithelial barrier and affects its integrity. Through gut-liver axis, gut microbiota may influence liver immune function. The release of lipopolysaccharides (LPS) from intestines to portal vein which are transported to the liver, may trigger hepatic inflammation, steatosis and even fibrosis. Moreover, the gut microbiome induces the conversion of primary bile acids (BAs) to secondary BAs, which activates intestinal receptors, such as FXR and TGR5. FXR activation decreases fat absorption and thus reduces hepatic lipid accumulation, while TGR5 activation promotes the release of glucagon-like peptide-1 (GLP-1) in blood. Furthermore, gut ethanol-producing bacteria has been implicated in NAFLD development. Additionally, in NAFLD there is a reduction in intestinal levels of short-chain fatty acids, such as butyrate, propionate and acetate. Many bacterial alterations have been observed in NAFLD, including the increased Bacteroidetes and decreased Firmicutes . Many probiotics have been tried in NAFLD prevention and management, including a plethora of strains from Lactobacilli , Bifidobacteria and Streptococcus and some of them have promising perspectives. There is also some promising data from the administration of prebiotics (such as inulin and fructo-oligosaccharides) and symbiotics (probiotics plus prebiotics). Faecal microbiota transplantation (FMT) is yet to be evaluated for its efficacy against NAFLD.

Schlagwörter

Stichwörter der Autor:innen

gut dysbiosisgut microbiomegut microbiotanon-alcoholic fatty liver disease (NAFLD)non-alcoholic steatohepatitis (NASH)

Autor:innen und Institutionen

  • Gastroenterology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Laboratory of Hygiene and Environmental Protection, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • School of Chemistry, University of Edinburgh, Scotland, United Kingdom.

Zitieren

APA

Mpountouridis, A., Tsigalou, C., Bezirtzoglou, I., Bezirtzoglou, E., & Stavropoulou, E. (2025). Gut microbiome in non-alcoholic fatty liver disease. Frontiers in Gastroenterology, 3. https://doi.org/10.3389/fgstr.2024.1534431

Vancouver

Mpountouridis A, Tsigalou C, Bezirtzoglou I, Bezirtzoglou E, Stavropoulou E. Gut microbiome in non-alcoholic fatty liver disease. Frontiers in Gastroenterology. 2025;3. doi:10.3389/fgstr.2024.1534431

BibTeX
@article{Mpountouridis2025,
  author = {Mpountouridis, Anastasios and Tsigalou, Christina and Bezirtzoglou, Ioanna and Bezirtzoglou, Eugenia and Stavropoulou, Elisavet},
  title = {Gut microbiome in non-alcoholic fatty liver disease},
  journal = {Frontiers in Gastroenterology},
  year = {2025},
  volume = {3},
  doi = {10.3389/fgstr.2024.1534431}
}
Kostenlos starten →